Lysolecithin induces demyelination in vitro in a cerebellar slice culture system

Journal of Neuroscience Research

Volumn 78, Issue 2, 2004, Pages 157-166

  Birgbauer, Eric ^a,e   Rao, Tadimeti S ^b,c   Webb, Michael ^a,d  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Merck Laboratories   (United States)

^c Kalypsys Inc   (United States)

^d JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

CNPase; MBP; MOG; Myelin; Myelination; Oligodendrocytes; Purkinje cells; Remyelination

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; LYSOPHOSPHATIDYLCHOLINE; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CELL DIFFERENTIATION; CEREBELLUM; DEMYELINATION; EXPERIMENTAL MODEL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MULTIPLE SCLEROSIS; MYELINATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; REMYELINIZATION; TISSUE CULTURE;

ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CEREBELLUM; CULTURE TECHNIQUES; DEMYELINATING DISEASES; LYSOPHOSPHATIDYLCHOLINES; MYELIN BASIC PROTEINS; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; NEURONS; PHOSPHORIC DIESTER HYDROLASES; RATS; RATS, SPRAGUE-DAWLEY; REGENERATION;

EID: 4744349978     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20248     Document Type: Article

References (53)

1. Avossa D, Rosato-Siri MD, Mazzarol F, Ballerini L. 2003. Spinal circuits formation: a study of developmentally regulated markers in organotypic cultures of embryonic mouse spinal cord. Neuroscience 122:391-405.
2. Barnett MH, Prineas JW. 2004. Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55:458-468.
3. Baron W, de Jonge JC, de Vries H, Hoekstra D. 2000. Perturbation of myelination by activation of distinct signaling pathways: in in vitro study in a myelinating culture derived from fetal rat brain. J Neurosci Res 59:74-85.
4. Barres BA, Raff MC. 1999. Axonal control of oligodendrocyte development. J Cell Biol 147:1123-1128.
5. Bassa BV, Roh DD, Vaziri ND, Kirschenbaum MA, Kamanna VS. 1999. Lysophosphatidylcholine activates mesangial cell PKC and MAP kinase by PLCgamma-1 and tyrosine kinase-Ras pathways. Am J Physiol 277:328-337.
6. Baumann N, Pham-Dinh D. 2001. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81:871-927.
7. Blakemore WF, Eames RA, Smith KJ, McDonald WI. 1977. Remyelination in the spinal cord of the cat following intraspinal injections of lysolecithin. J Neurol Sci 33:31-43.
8. Chang A, Tourtellotte WW, Rudick N, Trapp BD. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med 346:165-173.
9. Dusart I, Airaksinen MS, Sotelo C. 1997. Purkinje cell survival and axonal regeneration are age dependent: an in vitro study. J Neurosci 17:3710-3726.
10. Edgar JM, Garbern J. 2004. The myelinated axon is dependent on the myelinating cell for support and maintenance: molecules involved. J Neurosci Res 76:593-598.
11. Franklin RJ. 2002. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705-714.
12. Ghoumari AM, Ibanez C, El-Etr M, Leclerc P, Eychenne B, O'Malley BW, Baulieu EE, Schumacher M. 2003. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J Neurochem 86:848-859.
13. Ghoumari AM, Wehrle R, De Zeeuw CI, Sotelo C, Dusart I. 2002. Inhibition of protein kinase C prevents Purkinje cell death but does not affect axonal regeneration. J Neurosci 22:3531-3542.
14. Hall SM. 1972. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci 10:535-546.
15. Hama K, Aoki J, Fukaya M, Kishi Y, Sakai T, Suzuki R, Ohta H, Yamori T, Watanabe M, Chun J, Arai H. 2004. Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem 279:17634-17639.
16. Jing Q, Xin SM, Zhang WB, Wang P, Qin YW, Pei G. 2000. Lysophosphatidylcholine activates p38 and p42/44 mitogen-activated protein kinases in monocytic THP-1 cells, but only p38 activation is involved in its stimulated chemotaxis. Circ Res 87:52-59.
17. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF. 2002. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 8:1115-1121.
18. Kabarowski JH, Zhu K, Le LQ, Witte ON, Xu Y. 2001. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293:702-705.
19. Keegan BM, Noseworthy JH. 2002. Multiple sclerosis. Annu Rev Med 53:285-302.
20. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-374.
21. Lee JC, Mayer-Proschel M, Rao MS. 2000. Gliogenesis in the central nervous system. Glia 30:105-121.
22. Levine JM, Reynolds R, Fawcett JW. 2001. The oligodendrocyte precursor cell in health and disease. Trends Neurosci 24:39-47.
23. Linnington C, Webb M, Woodhams PL. 1984. A novel myelin-associated glycoprotein defined by a mouse monoclonal antibody. J Neuroimmunol 6:387-396.
24. Lubetzki C, Demerens C, Anglade P, Villarroya H, Frankfurter A, Lee VM, Zalc B. 1993. Even in culture, oligodendrocytes myelinate solely axons. Proc Natl Acad Sci USA 90:6820-6824.
25. Matsushima S, Machi N, Marumo M, Mizuno A. 1986. 2′,3′-cyclic nucleotide 3′-phosphohydrolase activity in rat visual pathways with experimental allergic encephalomyelitis. Jpn J Ophthalmol 30:74-81.
26. Meyer-Franke A, Shen S, Barres BA. 1999. Astrocytes induce oligodendrocyte processes to align with and adhere to axons. Mol Cell Neurosci 14:385-397.
27. Monge M, Kadiiski D, Jacque CM, Zalc B. 1986. Oligodendroglial expression and deposition of four major myelin constituents in the myelin sheath during development. An in vivo study. Dev Neurosci 8:222-235.
28. Niehaus A, Shi J, Grzenkowski M, Diers-Fenger M, Archelos J, Hartung HP, Toyka K, Bruck W, Trotter J. 2000. Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: implications for remyelination. Ann Neurol 48:362-371.
29. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. 2000. Multiple sclerosis. N Engl J Med 343:938-952.
30. Notterpek LM, Bullock PN, Malek-Hedayat S, Fisher R, Rome LH. 1993. Myelination in cerebellar slice cultures: development of a system amenable to biochemical analysis. J Neurosci Res 36:621-634.
31. Olafson RW, Drummond GI, Lee JF. 1969. Studies on 2′,3′- cyclic nucleotide-3′-phosphohydrolase from brain. Can J Biochem 47:961-966.
32. Pouly S, Storch MK, Matthieu JM, Lassmann H, Monnet-Tschudi F, Honegger P. 1997. Demyelination induced by protein kinase C-activating tumor promoters in aggregating brain cell cultures. J Neurosci Res 49:121-132.
33. Prineas JW, Barnard RO, Revesz T, Kwon EE, Sharer L, Cho ES. 1993. Multiple sclerosis. Pathology of recurrent lesions. Brain 116:681-693.
34. Reynolds R, Wilkin GP. 1988. Development of macroglial cells in rat cerebellum. 11. An in situ immunohistochemical study of oligodendroglial lineage from precursor to mature myelinating cell. Development 102:409-425.
35. Schachner M, Kim SK, Zehnle R. 1981. Developmental expression in central and peripheral nervous system of oligodendrocyte cell surface antigens (O antigens) recognized by monoclonal antibodies. Dev Biol 83:328-338.
36. Schnadelbach O, Ozen I, Blaschuk OW, Gour BJ, Meyer RL, Fawcett JW. 2001. N-cadherin is involved in axon-oligodendrocyte contact and myelination. Mol Cell Neurosci 17:1084-1093.
37. Scolding NJ, Frith S, Linington C, Morgan BP, Campbell AK, Compston DA. 1989. Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation. J Neuroimmunol 22:169-176.
38. Solly SK, Thomas JL, Monge M, Demerens C. Lubetzki C, Gardimer MV, Matthieu JM, Zalc B. 1996. Myelin/oligodendrocyte glycoprotein (MOG) expression is associated with myelin deposition. Glia 18:39-48.
39. Sommer I, Schachner M. 1981. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol 83:311-327.
40. Sprinkle TJ. 1989. 2′,3′-cyclic nucleotide 3′-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system. Crit Rev Neurobiol 4:235-301.
41. Steinman L. 1999. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 24:511-514.
42. Stoppini L, Buchs PA, Muller D. 1991. A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37:173-182.
43. Tokumura A, Harada K, Fukuzawa K, Tsukatani H. 1986. Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. Biochim Biophys Acta 875:31-38.
44. Tokumura A, Majima E, Kariya Y, Tominaga K, Kogure K, Yasuda K, Fukuzawa K. 2002. Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J Biol Chem 277:39436-39442.
45. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. 1998. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.
46. Tsukada Y, Nagai K, Suda H. 1980. A rapid micro method for 2′,3′-cyclic nucleotide 3′-phosphohydrolase assay using micro high performance liquid chromatography. J Neurochem 34:1019-1022.
47. Voogd J, Glickstein M. 1998. The anatomy of the cerebellum. Trends Neurosci 21:370-375.
48. Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, Hicks C, Weinmaster G, Barres BA. 1998. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21:63-75.
49. Wolswijk G. 2000. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis. Brain 123:105-115.
50. Woodruff RH, Franklin PJ. 1999. Demyelination and remyelination of the caudal cerebellar peduncle of adult rats following stereotaxic injections of lysolecithin, ethidium bromide, and complement/anti-galactocerebroside: a comparative study. Glia 25:216-228.
51. Xu Y. 2002. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim Biophys Acta 1582:81-88.
52. Yin X, Kidd GJ, Pioro EP, McDonough J, Dutta R, Feltri ML, Wrabetz L, Messing A, Wyatt RM, Balice-Gordon RJ, Trapp BD. 2004. Dysmyelinated lower motor neurons retract and regenerate dysfunctional synaptic terminals. J Neurosci 24:3890-3898.
53. Zhu K, Baudhuin LM, Hong G, Williams FS, Cristina KL, Kabarowski JH, Witte ON, Xu Y. 2001. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem 276:41325-41335.